title: A crossover study of prolactin changes associated with risperidone and olanzapine.
authors.forename: Cher-Yeang
authors.initials: CY
authors.lastname: Lin
authors.forename: Po-Lun
authors.initials: PL
authors.lastname: Wu
authors.forename: Carmine M
authors.initials: CM
authors.lastname: Pariante
authors.forename: Kuan-Pin
authors.initials: KP
authors.lastname: Su
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D011388:Prolactin / Q000097:blood*; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy*; D017678:Sex Distribution; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D011388:Prolactin; D018967:Risperidone; D000077152:Olanzapine